Evidence map›Paper›PMID 34035265›Full record

ArticleNature communications2021

Sulfide catabolism ameliorates hypoxic brain injury.

Eizo Marutani, Masanobu Morita, Shuichi Hirai, Shinichi Kai, Robert M H Grange, Yusuke Miyazaki, Fumiaki Nagashima, Lisa Traeger, Aurora Magliocca, Tomoaki Ida and 23 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 135 citations in OpenAlex.

  1. Article
  2. Article
  3. CoQExperimental & molecular medicine · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Hydrogen Sulfide Signaling in Neurodegenerative Movement Disorders.Handbook of experimental pharmacology · 2026
    Review
  12. Article
  13. Power and poison: The intersections of HThe Journal of biological chemistry · 2025
    Review
  14. Article
  15. Article
  16. Hydrogen sulfide/polysulfides signaling and neuronal diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  17. Article
  18. Gut sulfide metabolism modulates behavior and brain bioenergetics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 13 institutions in 2 countries.

Eizo Marutani *Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Masanobu Morita *Department of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shuichi Hirai *Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Shinichi KaiAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-1804-3071
Robert M H GrangeAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Yusuke MiyazakiAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Fumiaki NagashimaAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Lisa TraegerAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Aurora MaglioccaAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Tomoaki IdaDepartment of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tetsuro MatsunagaDepartment of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Daniel R FlickerDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA.
Benjamin CormanAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Naohiro MoriAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Yumiko YamazakiAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Annabelle BattenAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Rebecca LiAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-1567-9541
Tomohiro TanakaDivision of Cardiocirculatory Signaling, National Institute for Physiological Sciences & Exploratory Research Center on Life and Living Systems & Center for Novel Science Initiatives, National Institutes of Natural Sciences, Okazaki, Japan.ORCID 0000-0001-7442-4912
Takamitsu IkedaAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-1245-2958
Akito NakagawaAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Dmitriy N AtochinHarvard Medical School, Boston, MA, USA.
Hideshi IharaDepartment of Biological Science, Graduate School of Science, Osaka Prefecture University, Osaka, Japan.ORCID 0000-0002-8971-5138
Benjamin A OlenchockHarvard Medical School, Boston, MA, USA.
Xinggui ShenDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA.
Motohiro NishidaDivision of Cardiocirculatory Signaling, National Institute for Physiological Sciences & Exploratory Research Center on Life and Living Systems & Center for Novel Science Initiatives, National Institutes of Natural Sciences, Okazaki, Japan.ORCID 0000-0002-2587-5458
Kenjiro HanaokaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.ORCID 0000-0003-0797-4038
Christopher G KevilDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA.ORCID 0000-0003-0863-7260
Ming XianDepartment of Chemistry, Brown University, Providence, RI, USA.
Donald B BlochAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Takaaki AkaikeDepartment of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Allyson G HindleAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-1983-9573
Hozumi MotohashiDepartment of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan. hozumim@med.tohoku.ac.jp.ORCID 0000-0002-7261-1033
Fumito IchinoseAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA. fichinose@mgh.harvard.edu.ORCID 0000-0003-4535-1632
Harvard University · USMassachusetts General Hospital · USTohoku University · JPLouisiana State University Health Sciences Center Shreveport · USBrigham and Women's Hospital · USBroad Institute · USBrown University · USKyushu University · JPNational Institutes of Natural Sciences · JPOsaka Prefecture University · JPThe University of Tokyo · JPTohoku Institute of Technology · JPUniversity of Nevada, Las Vegas · US

Funding

Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female HeartP20GM121307 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Christopher G Kevil · 2018 to 2026
$23.6M
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUSR01HL101930 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ICHINOSE, FUMITO · 2010 to 2014
$2.1M
Hydrogen sulfide and vascular remodelingR01HL113303 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI KEVIL, CHRISTOPHER G · 2012 to 2016
$1.8M
cGMP-dependent protein kinase I as a new target against strokeR01NS096237 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ATOCHIN, DMITRIY · 2016 to 2020
$1.8M
Role of sulfide catabolism in ischemic brain injuryR01NS112373 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ICHINOSE, FUMITO · 2019 to 2023
$1.7M
CSE regulation of vascular remodelingR01HL149264 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI KEVIL, CHRISTOPHER G · 2020 to 2023
$1.7M
Novel Antidotes for H2S PoisoningR21NS116671 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ICHINOSE, FUMITO, XIAN, MING · 2020 to 2021
$437k
Howard Hughes Medical InstituteNHLBI NIH HHS R01 HL101930NHLBI NIH HHS R01 HL113303NHLBI NIH HHS R01 HL149264NIGMS NIH HHS P20 GM121307NINDS NIH HHS R01 NS096237NINDS NIH HHS R01 NS112373NINDS NIH HHS R21 NS116671
6 · The paper itself

Abstract

The mammalian brain is highly vulnerable to oxygen deprivation, yet the mechanism underlying the brain's sensitivity to hypoxia is incompletely understood. Hypoxia induces accumulation of hydrogen sulfide, a gas that inhibits mitochondrial respiration. Here, we show that, in mice, rats, and naturally hypoxia-tolerant ground squirrels, the sensitivity of the brain to hypoxia is inversely related to the levels of sulfide:quinone oxidoreductase (SQOR) and the capacity to catabolize sulfide. Silencing SQOR increased the sensitivity of the brain to hypoxia, whereas neuron-specific SQOR expression prevented hypoxia-induced sulfide accumulation, bioenergetic failure, and ischemic brain injury. Excluding SQOR from mitochondria increased sensitivity to hypoxia not only in the brain but also in heart and liver. Pharmacological scavenging of sulfide maintained mitochondrial respiration in hypoxic neurons and made mice resistant to hypoxia. These results illuminate the critical role of sulfide catabolism in energy homeostasis during hypoxia and identify a therapeutic target for ischemic brain injury.

Indexed as

AnimalsBrainBrain InjuriesCells, CulturedFemaleHydrogen SulfideHypoxiaMaleMembrane Potential, MitochondrialMiceMice, Inbred C57BLMice, Inbred DBAMice, KnockoutMitochondriaNADQuinone ReductasesHydrogen SulfideNADQuinone Reductasessulfide quinone reductase

Identifiers

PMID34035265
PMCPMC8149856
OpenAlexW3165187170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.